SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

4 h delay

Buys Sells Buys and sells Any size $100K+$1M+

Pro filters

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$1.6M−11.0%Mar 11

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$1.6M−11.0%Feb 12

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$4.8M−28.0%Jan 9

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$2.0M−22.0%Dec 12

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$889K−13.0%Nov 13

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$866K−14.0%Oct 10

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$920K−15.0%Sep 11

KRTXSell

Karuna Therapeutics, Inc.

Jeffrey M Jonas · Director

$2.6M−93.0%Sep 5

KRTXSell

Karuna Therapeutics, Inc.

Troy A. Ignelzi · CFO

$263K−5.0%Aug 24

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$902K−16.0%Aug 10

KRTXSell

Karuna Therapeutics, Inc.

Jeffrey M Jonas · Director

$2.7M−93.0%Aug 2

KRTXSell

Karuna Therapeutics, Inc.

Laurie J Olson · Director

$216K−50.0%Jul 5

KRTXSell

Karuna Therapeutics, Inc.

Jeffrey M Jonas · Director

$3.0M−93.0%Jul 5

KRTXSell

Karuna Therapeutics, Inc.

Troy A. Ignelzi · CFO

$2.0M−23.0%May 25

KRTXSell

Karuna Therapeutics, Inc.

Andrew Craig Miller · COO

$9.0M−65.0%Apr 20

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$884K−17.0%Apr 12

KRTXSell

Karuna Therapeutics, Inc.

Laurie J Olson · Director

$181K−100.0%Apr 5

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$948K−17.0%Mar 9

KRTXSell

Karuna Therapeutics, Inc.

Troy A. Ignelzi · CFO

$1.1M−16.0%Feb 23

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$962K−17.0%Feb 13

KRTXSell

Karuna Therapeutics, Inc.

Troy A. Ignelzi · CFO

$205K−4.0%Jan 19

KRTXSell

Karuna Therapeutics, Inc.

James Healy · Director

$1.2MJan 17

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$988K−25.0%Jan 9

KRTXSell

Karuna Therapeutics, Inc.

Laurie J Olson · Director

$197K−100.0%Jan 5

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$1.0M−25.0%Dec 12

KRTXSell

Karuna Therapeutics, Inc.

Andrew Craig Miller · COO

$3.4M−57.0%Dec 2

KRTXSell

Karuna Therapeutics, Inc.

Troy A. Ignelzi · CFO

$3.7M−62.0%Nov 17

KRTXSell

Karuna Therapeutics, Inc.

Andrew Craig Miller · COO

$3.4M−37.0%Nov 14

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$1.1M−25.0%Nov 10

KRTXSell

Karuna Therapeutics, Inc.

Andrew Craig Miller · COO

$3.4M−28.0%Nov 3

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$1.0M−25.0%Oct 12

KRTXSell

Karuna Therapeutics, Inc.

Laurie J Olson · Director

$206K−100.0%Oct 12

KRTXSell

Karuna Therapeutics, Inc.

Troy A. Ignelzi · CFO

$3.4M−60.0%Oct 4

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$1.2M−25.0%Sep 12

KRTXSell

Karuna Therapeutics, Inc.

Laurie J Olson · Director

$268K−100.0%Aug 16

KRTXSell

Karuna Therapeutics, Inc.

Troy A. Ignelzi · CFO

$3.8M−40.0%Aug 11

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$5.7M−63.0%Aug 11

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$2.0M−50.0%Jul 11

KRTXBuy

Karuna Therapeutics, Inc.

James Healy · Director

$14.7M+6.0%Jul 1

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$555K−25.0%Jun 9

KRTXSell

Karuna Therapeutics, Inc.

Laurie J Olson · Director

$110K−100.0%May 31

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$521K−25.0%May 9

KRTXSell

Karuna Therapeutics, Inc.

Troy A. Ignelzi · CFO

$557K−15.0%Apr 21

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$993K−34.0%Apr 4

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$830K−38.0%Mar 2

KRTXSell

Karuna Therapeutics, Inc.

Troy A. Ignelzi · CFO

$167K−6.0%Feb 17

KRTXSell

Karuna Therapeutics, Inc.

Laurie J Olson · Director

$110K−100.0%Feb 17

KRTXSell

Karuna Therapeutics, Inc.

Atul Pande · Director

$277K−100.0%Feb 2

KRTXSell

Karuna Therapeutics, Inc.

Stephen K. Brannan · Chief Medical Officer

$850K−44.0%Feb 2

KRTXSell

Karuna Therapeutics, Inc.

Atul Pande · Director

$326K−100.0%Jan 3

Older filings

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.